Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia

Overview of attention for article published in Research and Reports in Urology, November 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#29 of 228)
High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

policy: 3 policy sources

Citations

dimensions_citation: 77 Dimensions

Readers on

mendeley: 57 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Vetenskaplig evidens för användning av Rezum (varm vattenånga) för behandling av godartad prostataförstoring

Cited by Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) on 22 Oct 2021

SBU is an independent national authority, tasked by the government with assessing health care and social service interventions from a broad perspective, covering medical, economic, ethical and social aspects.

Minimally invasive therapies for benign prostatic hyperplasia (BPH)

Cited by Canadian Agency for Drugs and Technologies in Health on 13 Feb 2020

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia : Overview final

Cited by National Institute for Health and Care Excellence on 21 Aug 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.